Election 2014
SENSEX NIFTY

Indian Pharma

Apr 16, 2014 at 09:15 | Source: Moneycontrol.com
The Indian rupee opened lower at 60.29 per dollar on Wednesday, down 7 paise compared to previous closing value of 60.22 a dollar.
Apr 16, 2014 at 08:49 | Source: Moneycontrol.com
US markets bounced back to end higher with the Nasdaq making its biggest turnaround in five years. Meanwhile, European markets slipped on Ukraine fears. And in Asia, Japanese shares extended gains.
Apr 16, 2014 at 08:21 | Source: CNBC-TV18
TCS | IndusInd Bank | Mindtree | Sanofi | Gujarat Pipavav Port | United Spirits | Crompton Greaves | Wipro | AstraZeneca Pharma | Reliance Power | IL&FS Transportation | IOC | Jubilant FoodWorks and DCB Bank are stocks, which are in the news today.
Apr 10, 2014 at 22:22 | Source: CNBC-TV18
DG Shah, Secretary General, Indian Pharmaceutical Association said, Inbound acquisitions are faster -- this needs to be compensated by MNCs. Companies will look for complimentary portfolios - larger companies are hungry for acquisitions. We have seen Elder-Torrent and now Sun-Ranbaxy, it has created a pressure."
Apr 10, 2014 at 09:15 | Source: Moneycontrol.com
The Indian rupee opened marginally higher by 9 paise at 60.04 per dollar versus 60.13 Wednesday. The dollar drifted at three-week lows against a basket of major currencies, having fallen for a fourth session after minutes from the Federal Reserve's March meeting disappointed dollar bulls.
Apr 09, 2014 at 10:05 | Source: Moneycontrol.com
According to Way2Wealth.com, on lower side put writing at 6600 will provide strong support whereas Nifty will face immediate resistance around 6780-6800 levels.
Apr 09, 2014 at 09:15 | Source: Moneycontrol.com
The Indian rupee opened higher by 13 paise at 59.98 per dollar versus 60.11 Monday.The dollar languished at three-week lows against a basket of major currencies, having broken decisively lower as the yen squeezed higher and even the euro gained a tailwind.
Apr 09, 2014 at 08:42 | Source: CNBC-TV18
Ranbaxy Labs | Tata Steel | Maruti Suzuki | DLF | Dhanlaxmi Bank | Amara Raja Batteries | Ramco Systems | Alstom India | Jaihind Projects | NCC | Atul | Gulf Oil Corporation | MCX | Financial Technologies | Suzlon Energy | Bayer Crop | Natco Pharma | YES Bank and Oil India are stocks, which are in the news today.
Apr 07, 2014 at 17:31 | Source: CNBC-TV18
The deal gives Ranbaxy 9 percent in Sun Pharma which is an all-stock deal. This could have been only pulled off by Sun Pharma, the Facebook equivalent of Indian pharma, says Sujay Shetty.
Apr 07, 2014 at 11:39 | Source: CNBC-TV18
The deal will not only make Sun Pharma Indias largest pharma company but also, the largest Indian pharma company in the US.
Messages on Indian Pharma »

aden_2013

Silver Member

6 Followers

Claris Lifesciences  

Every Big pharma company is a small company when started and great support find for Indian Pharma.....This is highly growth sector.......Hold

11.25 AM Apr 15th

Web Messenger

Platinum Member

208614 Followers

Sun Pharma  

Source:Business Today - In what is being described by a landmark deal in Indian pharma, Sun Pharma and Ranbaxy on Monday morning announced that Sun Pharma is to acquire Ranbaxy in an all stock $ 4 billion deal. According to a release from Sun Pharma, it is to create world`s 5th largest specialty

3.50 PM Apr 10th

sathiboy

Gold Member

15 Followers

Wockhardt  

Anyhow Wockhard is the cheapest A group stock available, wockhard in not worth 622, it is more than that: Actually Wockhardt is not a small company based on many parameters. It is one of the largest Indian pharma company and a pioneer in Indian Bio-pharma space with a turnover of more than Rs.5000

2.21 PM Apr 9th

R Jagannathan

Platinum Member

889 Followers

Ranbaxy Labs  

Ranbaxy. One should expect the Indian pharma industry to get into another feeding frenzy of mergers and consolidation once Sun-Ranbaxy is consummated. This is because the merged company will be so far ahead of the rest that the rest will have to consider the need for scaling up. Both the global whales

11.06 AM Apr 9th

Web Messenger

Platinum Member

208614 Followers

Ranbaxy Labs  

Source:Economic Times - Japanese innovator drugmaker Daiichi Sankyo bought Ranbaxy in 2008 for $4.6 billion with an intention to enter the generics space by acquiring the largest Indian pharma company. However, it faced daunting challenges in the pursuit. A series of import bans on each of Ranbaxy

3.37 PM Apr 8th

kumarhansra
j

New Member

0 Follower

Sun Pharma  

SUN PHARMA IS ALREADY ONE OF THE TOP INDIAN PHARMA SECTOR & AQUIRING RANBAXY WILL CATAPULT IT INTO TOP MOST ORBIT OF PHARMA PRODUCTS MANUFACTURING SECTOR..KUMAR HANSRAJ

6.46 PM Apr 7th

jaisriram

Silver Member

0 Follower

Sun Pharma  

This makes Sun Pharma as worlds 5th largest company, and gives immense power and reach to the global market. Great Indian consolidation, good for Indian Pharma industry.

6.24 PM Apr 7th

Web Messenger

Platinum Member

208614 Followers

Sun Pharma  

Source:Economic Times - With two leading players of the Indian pharma market joining hands, the already intensely competitive market will see further increase in competition. The combined market share of Sun Pharma (5.4%) and Ranbaxy (3.8%) is going to be a formidable 9.2% - much higher than

4.31 PM Apr 7th

Omar_An

Silver Member

0 Follower

Sun Pharma  

Sun Pharma management said combined entity would have a 9% market share in Indian pharma market. It would also have presence in 55 markets across the globe

12.41 PM Apr 7th

Ranbaxy Labs  

Ranbaxy brought a bad name to entire Indian Pharma Industry. It`s sad to see that a company which at one time was known as Pride of India is being looked as fraudulent and being compared with Satyam. Malvinder was knowing of all the wrong doings and malpractices which Ranbaxy adopted to get

12.35 PM Apr 7th

News across the web »
Apr 17, 2014 at 12:37 | Source: Economic Times
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.